As populations age and health systems face mounting pressures, precision medicine offers a powerful shift from reactive treatment to proactive, personalized prevention. However, key hurdles remain, from breaking down data silos and navigating provincial jurisdictions to maintaining public trust and closing equity gaps across rural and urban communities.
đź’¬ This episode features Dr. Rob Annan, President & CEO, Genome Canada, and Dr. Jim Woodgett, President and Scientific Director, Terry Fox Research Institute. Hosted by David Jones, Managing Director at Merck Canada.
Read the full interview and key takeaways: https://thefutureeconomy.ca/interviews/canadas-precision-medicine-opportunity-from-data-and-prevention-to-better-care/
Explore the series here: https://thefutureeconomy.ca/content-series/the-future-of-life-sciences/
Watch more videos from the series: https://www.youtube.com/playlist?list=PLSGOnbotjlBE
Subscribe for exclusive previews of upcoming episodes and updates on new releases: https://bit.ly/3ri2IUu
Follow us on social media: https://linkin.bio/thefutureeconomy.ca
=====
About TheFutureEconomy.ca
=====
TheFutureEconomy.ca is a Canadian media and thought leadership platform that produces expert series, featured interviews and op-eds with leaders from industry, government, academia and more to define a strong vision for our future economy.
Our content emphasizes our interviewees’ insights and calls-to-action on what we must do now to improve the competitiveness of Canada’s future economy.
Check out our website: https://thefutureeconomy.ca/
#FutureOfLifeSciences #PrecisionMedicine #Genomics #CancerResearch #HealthcareInnovation #HealthEconomics #LifeSciences #CanadianHealthcare